The market for a first oral testosterone on the market should be big. $18 a share was around the 52 week high before any approval. I would think it would go there.
You are right...they owned 5% of LPCN. One million shares of LPCN is going to affect LPCN a lot more than say one million shares Biogene. Hiwatt1959 is a short.
Wow this could really explain the poor price action in the last couple months. I have been concerned about LPCN's chances of approval since watching the poor performance. Now I'm beginning to think this is just stock being liquidated by Visium because they need the cash, not because LPCN has a bad chance to be approved. One could hope!
Thanks... just a long with concerns....Am I to assume any long with a concern is a secret short?